News

Program is part of association's broader efforts to illustrate the impact of distributors on US healthcare ecosystem

Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies

Cell culture facility expected to be largest in North America, according to the manufacturer

2020 was a difficult year for many patients, but new data may signal a brighter future ahead

Location will be purchased by WuXi Biologics, according to report

New refrigerators include -80°C (-112°F) service

The commission is launching a broad review of drug-company mergers to explore how such deals can potentially harm industry competition

Production will occur at IDT’s Germany facilities for a three-month span

Agreement focused on enhancing insights into the location and condition of temperature-sensitive drugs and vaccines, including ones for Covid-19

Deal bolsters ANI’s generics and CDMO portfolio

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Covid-19 has sped up the adoption of artificial intelligence in the life sciences and healthcare, but business leaders are confident in its effectiveness, report finds

Raises projected supply of one-dose shot to 200 million

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Puts packaging business on pace for 2 billion by end of year

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

Virtually guided tests will be distributed to pharmacies across the country

The 130,000-square-foot site will be the CDMO's third location

Ten million doses expected by end of Q3

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Latest report shows that air cargo demand has reached pre-Covid levels

Drone technology delivers doses to difficult-to-reach locations

In extension of J&J agreement, deal provides manufacturing facilities for Covid-19 vaccine production

Rivals will team up in order to accelerate supply

UK-based OXGENE designs and develops scalable gene therapy technologies

Purchase expands CRO's plans for cell and gene therapy program